Chemoinformaics analysis of Terebenthifolic acid
| Molecular Weight | 454.695 | nRot | 1 |
| Heavy Atom Molecular Weight | 408.327 | nRig | 28 |
| Exact Molecular Weight | 454.345 | nRing | 5 |
| Solubility: LogS | -5.249 | nHRing | 0 |
| Solubility: LogP | 6.713 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 83.1785 |
| nHD | 1 | BPOL | 47.8835 |
| QED | 0.423 |
| Synth | 4.865 |
| Natural Product Likeliness | 3.343 |
| NR-PPAR-gamma | 0.029 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.229 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -5.417 |
| MDCK | 0.00000958 |
| BBB | 0.3 |
| PPB | 0.963633 |
| VDSS | 0.766 |
| FU | 0.0220393 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.806 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.922 |
| CYP2c9-inh | 0.211 |
| CYP2c9-sub | 0.759 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.121 |
| CYP3a4-inh | 0.693 |
| CYP3a4-sub | 0.635 |
| CL | 4.636 |
| T12 | 0.112 |
| hERG | 0.006 |
| Ames | 0.007 |
| ROA | 0.757 |
| SkinSen | 0.049 |
| Carcinogencity | 0.453 |
| EI | 0.199 |
| Respiratory | 0.982 |
| NR-Aromatase | 0.796 |
| Antiviral | No |
| Prediction | 0.595824 |